Advanced search
Publication Cover
mAbs Volume 9, 2017 - Issue 2
Submit an article Journal homepage
16,855
Views
208
CrossRef citations to date
0
Altmetric
Perspective

Antibodies to watch in 2017

Janice M. Reichert Executive Director, The Antibody Society, Framingham, MA, USACorrespondence[email protected]
Pages 167-181 | Received 05 Dec 2016, Accepted 05 Dec 2016, Published online: 20 Jan 2017

Citations (208)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (30)

Kyle P. Martin, Christine Grimaldi, Rolf Grempler, Steven Hansel & Sandeep Kumar. (2023) Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics. mAbs 15:1.
Read now
Hélène Kaplon, Silvia Crescioli, Alicia Chenoweth, Jyothsna Visweswaraiah & Janice M. Reichert. (2023) Antibodies to watch in 2023. mAbs 15:1.
Read now
Md Harunur Rashid. (2022) Full-length recombinant antibodies from Escherichia coli: production, characterization, effector function (Fc) engineering, and clinical evaluation. mAbs 14:1.
Read now
Hélène Kaplon & Janice M. Reichert. (2021) Antibodies to watch in 2021. mAbs 13:1.
Read now
Zhiqiang Chen, Yueming Qian, Yuanli Song, Xuankuo Xu, Li Tao, Nesredin Mussa, Sanchayita Ghose & Zheng Jian Li. (2020) Design of next-generation therapeutic IgG4 with improved manufacturability and bioanalytical characteristics. mAbs 12:1.
Read now
Monica L. Fernández-Quintero, Martin C. Heiss, Nancy D. Pomarici, Barbara A. Math & Klaus R. Liedl. (2020) Antibody CDR loops as ensembles in solution vs. canonical clusters from X-ray structures. mAbs 12:1.
Read now
Hélène Kaplon, Mrinalini Muralidharan, Zita Schneider & Janice M. Reichert. (2020) Antibodies to watch in 2020. mAbs 12:1.
Read now
Sameer Joshi, Swapnil Bawage, Pooja Tiwari, Daniel Kirby, Yvonne Perrie, Vida Dennis & Shree R Singh. (2019) Liposomes: a promising carrier for respiratory syncytial virus therapeutics. Expert Opinion on Drug Delivery 16:9, pages 969-980.
Read now
Monica L. Fernández-Quintero, Johannes Kraml, Guy Georges & Klaus R. Liedl. (2019) CDR-H3 loop ensemble in solution – conformational selection upon antibody binding. mAbs 11:6, pages 1077-1088.
Read now
Hélène Kaplon & Janice M. Reichert. (2019) Antibodies to watch in 2019. mAbs 11:2, pages 219-238.
Read now
Adriana-Michelle Wolf Pérez, Pietro Sormanni, Jonathan Sonne Andersen, Laila Ismail Sakhnini, Ileana Rodriguez-Leon, Jais Rose Bjelke, Annette Juhl Gajhede, Leonardo De Maria, Daniel E. Otzen, Michele Vendruscolo & Nikolai Lorenzen. (2019) In vitro and in silico assessment of the developability of a designed monoclonal antibody library. mAbs 11:2, pages 388-400.
Read now
Justina P Tavana, Matthew Rosene, Nick O Jensen, Perry G Ridge, John SK Kauwe & Celeste M Karch. (2019) RAB10: an Alzheimer’s disease resilience locus and potential drug target. Clinical Interventions in Aging 14, pages 73-79.
Read now
Brian J. Booth, Boopathy Ramakrishnan, Kristin Narayan, Andrew M. Wollacott, Gregory J. Babcock, Zachary Shriver & Karthik Viswanathan. (2018) Extending human IgG half-life using structure-guided design. mAbs 10:7, pages 1098-1110.
Read now
Claudio Marasca, Maria Carmela Annunziata, Maddalena Napolitano & Gabriella Fabbrocini. (2018) Unconventional therapies for hidradenitis suppurativa. Expert Review of Clinical Pharmacology 11:9, pages 879-887.
Read now
Natasha A. Pereira, Kah Fai Chan, Pao Chun Lin & Zhiwei Song. (2018) The “less-is-more” in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity. mAbs 10:5, pages 693-711.
Read now
Wolfgang F. Richter, Gregory J. Christianson, Nicolas Frances, Hans Peter Grimm, Gabriele Proetzel & Derry C. Roopenian. (2018) Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice. mAbs 10:5, pages 803-813.
Read now
Melody Maarouf, Ashley K. Clark, Dylan E. Lee & Vivian Y. Shi. (2018) Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials. Journal of Dermatological Treatment 29:5, pages 441-449.
Read now
Peng Luan, Sophia Lee, Tia A. Arena, Maciej Paluch, Joe Kansopon, Sharon Viajar, Zahira Begum, Nancy Chiang, Gerald Nakamura, Philip E. Hass, Athena W. Wong, Greg A. Lazar & Avinash Gill. (2018) Automated high throughput microscale antibody purification workflows for accelerating antibody discovery. mAbs 10:4, pages 624-635.
Read now
Brunella Posteraro, Federico Pea, Luca Masucci, Patrizia Posteraro & Maurizio Sanguinetti. (2018) Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment?. Expert Opinion on Biological Therapy 18:4, pages 469-476.
Read now
Patrick J. Kennedy, Carla Oliveira, Pedro L. Granja & Bruno Sarmento. (2018) Monoclonal antibodies: technologies for early discovery and engineering. Critical Reviews in Biotechnology 38:3, pages 394-408.
Read now
Laura Kuhlmann, Emma Cummins, Ismael Samudio & Thomas Kislinger. (2018) Cell-surface proteomics for the identification of novel therapeutic targets in cancer. Expert Review of Proteomics 15:3, pages 259-275.
Read now
Hélène Kaplon & Janice M. Reichert. (2018) Antibodies to watch in 2018. mAbs 10:2, pages 183-203.
Read now
Anil Wagh, Hangtian Song, Ming Zeng, Li Tao & Tapan K. Das. (2018) Challenges and new frontiers in analytical characterization of antibody-drug conjugates. mAbs 10:2, pages 222-243.
Read now
Annalisa Tonini, Bruno Gualtieri, Salvatore Panduri, Marco Romanelli & Andrea Chiricozzi. (2018) A new class of biologic agents facing the therapeutic paradigm in psoriasis: anti-IL-23 agents.. Expert Opinion on Biological Therapy 18:2, pages 135-148.
Read now
Kathryn H. Ching, Ellen J. Collarini, Yasmina N. Abdiche, Daniel Bedinger, Darlene Pedersen, Shelley Izquierdo, Rian Harriman, Lei Zhu, Robert J. Etches, Marie-Cecile van de Lavoir, William D. Harriman & Philip A. Leighton. (2018) Chickens with humanized immunoglobulin genes generate antibodies with high affinity and broad epitope coverage to conserved targets. mAbs 10:1, pages 71-80.
Read now
Guillaume Terral, Thierry Champion, François Debaene, Olivier Colas, Maxime Bourguet, Elsa Wagner-Rousset, Nathalie Corvaia, Alain Beck & Sarah Cianferani. (2017) Epitope characterization of anti-JAM-A antibodies using orthogonal mass spectrometry and surface plasmon resonance approaches. mAbs 9:8, pages 1317-1326.
Read now
Danlin Yang, Rachel Kroe-Barrett, Sanjaya Singh, Christopher J. Roberts & Thomas M. Laue. (2017) IgG cooperativity – Is there allostery? Implications for antibody functions and therapeutic antibody development. mAbs 9:8, pages 1231-1252.
Read now
François Griaud, Andrej Winter, Blandine Denefeld, Manuel Lang, Héloïse Hensinger, Frank Straube, Mirko Sackewitz & Matthias Berg. (2017) Identification of multiple serine to asparagine sequence variation sites in an intended copy product of LUCENTIS® by mass spectrometry. mAbs 9:8, pages 1337-1348.
Read now
Gillian Dekkers, Arthur E. H. Bentlage, Tamara C. Stegmann, Heather L. Howie, Suzanne Lissenberg-Thunnissen, James Zimring, Theo Rispens & Gestur Vidarsson. (2017) Affinity of human IgG subclasses to mouse Fc gamma receptors. mAbs 9:5, pages 767-773.
Read now
Thomas Botzanowski, Stéphane Erb, Oscar Hernandez-Alba, Anthony Ehkirch, Olivier Colas, Elsa Wagner-Rousset, David Rabuka, Alain Beck, Penelope M. Drake & Sarah Cianférani. (2017) Insights from native mass spectrometry approaches for top- and middle- level characterization of site-specific antibody-drug conjugates. mAbs 9:5, pages 801-811.
Read now

Articles from other publishers (178)

Zhuofan Deng, Shengkun Zhang, Meiqi Sun, Haotian Yang, Ying Lu, Maopeng Wang, Weihuan Fang, Fushan Shi & Fang He. (2023) Nanobodies against porcine CD163 as PRRSV broad inhibitor. International Journal of Biological Macromolecules 253, pages 127493.
Crossref
Susanna Esposito, Gayatri Amirthalingam, Matteo Bassetti, Francesco Blasi, Francesco Giuseppe De Rosa, Natasha B. Halasa, Ivan Hung, Albert Osterhaus, Tina Tan, Juan Pablo Torres, Antonio Vena & Nicola Principi. (2023) Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy. Frontiers in Immunology 14.
Crossref
Ziqian Yin, Youjia Qiu, Aojie Duan, Ting Fang, Zhouqing Chen, Jiang Wu, Zhong Wang & Gang Chen. (2023) Different monoclonal antibodies and immunosuppressants administration in patients with neuromyelitis optica spectrum disorder: a Bayesian network meta-analysis. Journal of Neurology.
Crossref
Jeffrey L. Bennett, Kazuo Fujihara, Ho Jin Kim, Romain Marignier, Kevin C. O'Connor, Robert C. Sergott, Anthony Traboulsee, Heinz Wiendl, Jens Wuerfel, Scott S. Zamvil, Veronica G. Anania, Regine Buffels, Thomas Künzel, Annemarie N. Lekkerkerker, Siân Lennon-Chrimes & Sean J. Pittock. (2023) SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab. Frontiers in Neurology 14.
Crossref
Micael G. Gouveia, Justus P. Wesseler, Jobbe Ramaekers, Christoph Weder, Philip B. V. Scholten & Nico Bruns. (2023) Polymersome-based protein drug delivery – quo vadis?. Chemical Society Reviews 52:2, pages 728-778.
Crossref
Walid Azab. 2023. Antimicrobial Activity of Nanoparticles. Antimicrobial Activity of Nanoparticles 133 154 .
Alf Spitschak, Shailendra Gupta, Krishna P. Singh, Stella Logotheti & Brigitte M. Pützer. (2022) Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease. Pharmaceutics 15:1, pages 83.
Crossref
Yan Huang, Ziding Zhang & Yuan Zhou. (2022) AbAgIntPre: A deep learning method for predicting antibody-antigen interactions based on sequence information. Frontiers in Immunology 13.
Crossref
Ryota Otsubo & Teruhito Yasui. (2022) Monoclonal antibody therapeutics for infectious diseases: Beyond normal human immunoglobulin. Pharmacology & Therapeutics 240, pages 108233.
Crossref
Yurij V. Kalyuzhnyi & Vojko Vlachy. (2022) Numerical analysis of the liquid-liquid phase separation in the antibody–human serum albumin mixtures in aqueous buffer solution. Journal of Molecular Liquids 365, pages 120006.
Crossref
Jinlu Zhang, Linlin Hu & Hua Shao. (2022) Research Progress on Quantification Methods of Drug Concentration of Monoclonal Antibodies. Current Pharmaceutical Analysis 18:7, pages 663-676.
Crossref
Deniz Akpinaroglu, Jeffrey A. Ruffolo, Sai Pooja Mahajan & Jeffrey J. Gray. (2022) Simultaneous prediction of antibody backbone and side-chain conformations with deep learning. PLOS ONE 17:6, pages e0258173.
Crossref
Algirdas Grevys, Rahel Frick, Simone Mester, Karine Flem-Karlsen, Jeannette Nilsen, Stian Foss, Kine Marita Knudsen Sand, Thomas Emrich, Jens Andre Alexander Fischer, Victor Greiff, Inger Sandlie, Tilman Schlothauer & Jan Terje Andersen. (2022) Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life. iScience 25:2, pages 103746.
Crossref
Helga Rübsamen‐Schaeff & Helmut BuschmannOliver Planz. 2022. New Drug Development for Known and Emerging Viruses. New Drug Development for Known and Emerging Viruses 59 96 .
Ritopa Das, Sofia Langou, Thinh T. Le, Pooja Prasad, Feng Lin & Thanh D. Nguyen. (2022) Electrical Stimulation for Immune Modulation in Cancer Treatments. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Pan Zhang, Shuangjia Zheng, Jianwen Chen, Yaoqi Zhou & Yuedong Yang. (2021) DeepANIS: Predicting antibody paratope from concatenated CDR sequences by integrating bidirectional long-short-term memory and transformer neural networks. DeepANIS: Predicting antibody paratope from concatenated CDR sequences by integrating bidirectional long-short-term memory and transformer neural networks.
Sanchita Mitra & Pushpa Chaudhary Tomar. (2021) Hybridoma technology; advancements, clinical significance, and future aspects. Journal of Genetic Engineering and Biotechnology 19:1.
Crossref
Yukio Takeshita, Susumu FujikawaKenichi SerizawaMiwako FujisawaKinya MatsuoJoe NemotoFumitaka ShimizuYasuteru SanoHaruna Tomizawa-ShinoharaShota Miyake, Richard M. RansohoffTakashi Kanda. (2021) New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD. Neurology Neuroimmunology & Neuroinflammation 8:6.
Crossref
Tomas Di Mambro, Tania Vanzolini, Pierpaolo Bruscolini, Sergio Perez-Gaviro, Emanuele Marra, Giuseppe Roscilli, Marzia Bianchi, Alessandra Fraternale, Giuditta Fiorella Schiavano, Barbara Canonico & Mauro Magnani. (2021) A new humanized antibody is effective against pathogenic fungi in vitro. Scientific Reports 11:1.
Crossref
S. Fernandez-Poza, A. Padros, R. Thompson, Lucy Butler, Meez Islam, J.A. Mosely, James H. Scrivens, Muhammad F Rehman & Muhammad Safwan Akram. (2021) Tailor-made recombinant prokaryotic lectins for characterisation of glycoproteins. Analytica Chimica Acta 1155, pages 338352.
Crossref
Andrew S. Thomson, Shing H. Mai, Gerben Bouma, Michael Herdman, Michael Byrne, Charles S. Hottenstein, Joseph Minetti, Stephen Trulli, J. David Taylor, John R. White & Shugui Chen. (2021) Structure and Functional Characterization of a Humanized Anti-CCL20 Antibody following Exposure to Serum Reveals the Formation of Immune Complex That Leads to Toxicity. The Journal of Immunology 206:5, pages 1067-1076.
Crossref
Fatma Betul Arslan, Kivilcim Ozturk & Sema Calis. (2021) Antibody-mediated drug delivery. International Journal of Pharmaceutics 596, pages 120268.
Crossref
Ekram Ahmed Chowdhury, Guy Meno-Tetang, Hsueh Yuan Chang, Shengjia Wu, Hsien Wei Huang, Tanguy Jamier, Jayanth Chandran & Dhaval K. Shah. (2021) Current progress and limitations of AAV mediated delivery of protein therapeutic genes and the importance of developing quantitative pharmacokinetic/pharmacodynamic (PK/PD) models. Advanced Drug Delivery Reviews 170, pages 214-237.
Crossref
Elisa Seria, Sarah Samut Tagliaferro, Doreen Cutajar, Ruth Galdies & Alex Felice. (2021) Immunoglobulin G in Platelet-Derived Wound Healing Factors. BioMed Research International 2021, pages 1-16.
Crossref
Amir-Hassan Zarnani, Davood Jafari, Mahmood Bozorgmehr, Mahdi Shabani, Leila Barzegar-Yarmohammadi, Fatemeh Ghaemimanesh & Mahmood Jeddi-Tehrani. 2021. Cancer Immunology. Cancer Immunology 273 312 .
Itay Lotan, Richard McGowan & Michael Levy. (2020) Anti-IL-6 Therapies for Neuromyelitis Optica Spectrum Disorders: A Systematic Review of Safety and Efficacy. Current Neuropharmacology 19:2, pages 220-232.
Crossref
Janet H. Ford, Tobias Kurth, Amaal J. Starling, David W. Ayer, Linda A. Wietecha, Martha D. Port, Mallikarjuna Rettiganti & Dustin D. Ruff. (2020) Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine. Headache: The Journal of Head and Face Pain 60:10, pages 2304-2319.
Crossref
Monica L. Fernández-Quintero, Nancy D. Pomarici, Barbara A. Math, Katharina B. Kroell, Franz Waibl, Alexander Bujotzek, Guy Georges & Klaus R. Liedl. (2020) Antibodies exhibit multiple paratope states influencing VH–VL domain orientations. Communications Biology 3:1.
Crossref
Lu Shan, Kimberly M. Cook, Nantaporn Haskins, Bilal Omar, Yu Jiang, Andrew Garcia, Adem Koksal, Vaheh Oganesyan, Kim Rosenthal, Herren Wu, William F. Dall’Acqua & Melissa M. Damschroder. (2020) Long-acting antibody ligand mimetics for HER4-selective agonism. Scientific Reports 10:1.
Crossref
Monica L. Fernández-Quintero, Johannes R. Loeffler, Lisa M. Bacher, Franz Waibl, Clarissa A. Seidler & Klaus R. Liedl. (2020) Local and Global Rigidification Upon Antibody Affinity Maturation. Frontiers in Molecular Biosciences 7.
Crossref
Masahiro Yasunaga. (2020) Antibody therapeutics and immunoregulation in cancer and autoimmune disease. Seminars in Cancer Biology 64, pages 1-12.
Crossref
Yinyan Xu, Yi Li, Jiahui Pan, Xing Kang, Xu Zhang, Xinyi Feng, Shucheng Li, Chengxi Li, Jinku Zhang, Chong Li & Guoqing Wang. (2020) EM2D9, A monoclonal antibody against integrin α5β1, has potent antitumor activity on endometrial cancer in vitro and in vivo. Cancer Letters 483, pages 66-74.
Crossref
Monica L. Fernández‐Quintero, Valentin J. Hoerschinger, Leonida M. Lamp, Alexander Bujotzek, Guy Georges & Klaus R. Liedl. (2020) V H ‐V L interdomain dynamics observed by computer simulations and NMR . Proteins: Structure, Function, and Bioinformatics 88:7, pages 830-839.
Crossref
Yumiko Masuda, Yuka Ogino, Kozo Yamaichi, Yusuke Takahashi, Koichi Nonaka & Kaori Wakamatsu. (2020) The prevention of an anomalous chromatographic behavior and the resulting successful removal of viruses from monoclonal antibody with an asymmetric charge distribution by using a membrane adsorber in highly efficient, anion‐exchange chromatography in flow‐through mode. Biotechnology Progress 36:3.
Crossref
Anne Bordron, Cristina Bagacean, Adrian Tempescul, Christian Berthou, Eléonore Bettacchioli, Sophie Hillion & Yves Renaudineau. (2019) Complement System: a Neglected Pathway in Immunotherapy. Clinical Reviews in Allergy & Immunology 58:2, pages 155-171.
Crossref
E. V. Shubnikova, T. M. Bukatina, N. Yu. Velts, D. A. Kaperko & G. V. Kutekhova. (2020) Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents. Safety and Risk of Pharmacotherapy 8:1, pages 9-22.
Crossref
J. Ailani, E. Pearlman, Q. Zhang, A. J. Nagy, K. Schuh & S. K. Aurora. (2019) Positive response to galcanezumab following treatment failure to onabotulinumtoxinA in patients with migraine: post hoc analyses of three randomized double‐blind studies . European Journal of Neurology 27:3, pages 542-549.
Crossref
Beatriz G. de la Torre & Fernando Albericio. (2020) The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules 25:3, pages 745.
Crossref
Guy J. Georges, Stefan Dengl, Alexander Bujotzek, Friederike Hesse, Jens A.A. Fischer, Achim Gärtner, Jörg Benz, Matthias E. Lauer, Philippe Ringler, Henning Stahlberg, Friederike Plath, Ulrich Brinkmann & Sabine Imhof-Jung. (2020) The Contorsbody, an antibody format for agonism: Design, structure, and function. Computational and Structural Biotechnology Journal 18, pages 1210-1220.
Crossref
Sebastian Daberdaku. 2020. Computational Intelligence Methods for Bioinformatics and Biostatistics. Computational Intelligence Methods for Bioinformatics and Biostatistics 27 49 .
Juliet Rashidian & Joshua Lloyd. 2020. Genotype Phenotype Coupling. Genotype Phenotype Coupling 423 441 .
Biancamaria Cembrola, Valentino Ruzza, Fulvia Troise, Maria Luisa Esposito, Emanuele Sasso, Valeria Cafaro, Margherita Passariello, Feliciano Visconte, Maddalena Raia, Luigi Del Vecchio, Anna Morena D’Alise, Riccardo Cortese, Elisa Scarselli, Nicola Zambrano, Claudia De Lorenzo & Alfredo Nicosia. (2019) Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries. BioMed Research International 2019, pages 1-22.
Crossref
Cheri L. Lamb, Emily Price, Kevin P. Field, Christopher Dayton, Eric R. McIndoo, Eva J. Katahira, Dennis L. Stevens & Sarah E. Hobdey. (2019) Enrichment of Antigen-Specific Class-Switched B Cells from Individuals Naturally Immunized by Infection with Group A Streptococcus. mSphere 4:6.
Crossref
Lien Van Hoecke & Kenny Roose. (2019) How mRNA therapeutics are entering the monoclonal antibody field. Journal of Translational Medicine 17:1.
Crossref
Wei Jiang & Meiju Ji. (2019) Receptor tyrosine kinases in PI3K signaling: The therapeutic targets in cancer. Seminars in Cancer Biology 59, pages 3-22.
Crossref
Takashi YamamuraIngo KleiterKazuo FujiharaJacqueline PalaceBenjamin GreenbergBeata Zakrzewska-PniewskaFrancesco PattiChing-Piao TsaiAlbert SaizHayato YamazakiYuichi KawataPadraig WrightJerome De Seze. (2019) Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder. New England Journal of Medicine 381:22, pages 2114-2124.
Crossref
Chantal Brämer, Lisa Tünnermann, Alina Gonzalez Salcedo, Oscar-Werner Reif, Dörte Solle, Thomas Scheper & Sascha Beutel. (2019) Membrane Adsorber for the Fast Purification of a Monoclonal Antibody Using Protein A Chromatography. Membranes 9:12, pages 159.
Crossref
Monica L. Fernández-Quintero, Barbara A. Math, Johannes R. Loeffler & Klaus R. Liedl. (2019) Transitions of CDR-L3 Loop Canonical Cluster Conformations on the Micro-to-Millisecond Timescale. Frontiers in Immunology 10.
Crossref
Miguel A. Soler, Barbara Medagli, Marta S. Semrau, Paola Storici, Gregor Bajc, Ario de Marco, Alessandro LaioSara Fortuna. (2019) A consensus protocol for the in silico optimisation of antibody fragments . Chemical Communications 55:93, pages 14043-14046.
Crossref
Chi Zhang, Jeremy S. Springall, Xiangyang Wang & Ishan Barman. (2019) Rapid, quantitative determination of aggregation and particle formation for antibody drug conjugate therapeutics with label-free Raman spectroscopy. Analytica Chimica Acta 1081, pages 138-145.
Crossref
Yuwei Deng, Lixiong Liu, Wei Qiang, Li Hu, Lei Wang & Zeneng Cheng. (2019) Methotrexate Reduces the Clearance of Adalimumab by Increasing the Concentration of Neonatal Fc Receptor in Tissues. Pharmaceutical Research 36:11.
Crossref
Hyun Woung Yoon, Migyeong Jo, Sanghwan Ko, Hyeong Sun Kwon, Chung Su Lim, Byoung Joon Ko, Ji Chul Lee & Sang Taek Jung. (2019) Optimal combination of beneficial mutations for improved ADCC effector function of aglycosylated antibodies. Molecular Immunology 114, pages 62-71.
Crossref
Anahita R. Chauhan, Yogeshwar S. Nandanwar, Aruna Ramaiah, Kanan A. Yelikar, M. D. Rashmi, Rekha Sachan, Rahul V. Mayekar, Yamini N. Trivedi, Gopalkrishna V. Paradkar & Kiran P. Patole. (2019) A Multicenter, Randomized, Open-Label Trial Comparing the Efficacy and Safety of Monoclonal Anti-Rh (D) Immunoglobulin with Polyclonal Anti-Rh (D) Immunoglobulin for the Prevention of Maternal Rh-Isoimmunization. The Journal of Obstetrics and Gynecology of India 69:5, pages 420-425.
Crossref
Fatemeh Yarian, Abbas Alibakhshi, Shirin Eyvazi, Roghaye Arezumand & Shahrzad Ahangarzadeh. (2019) Antibody‐drug therapeutic conjugates: Potential of antibody‐siRNAs in cancer therapy. Journal of Cellular Physiology 234:10, pages 16724-16738.
Crossref
Margherita Passariello, Anna Morena D’Alise, Annachiara Esposito, Cinzia Vetrei, Guendalina Froechlich, Elisa Scarselli, Alfredo Nicosia & Claudia De Lorenzo. (2019) Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling. Scientific Reports 9:1.
Crossref
Gaurav Bajaj, Satyendra Suryawanshi, Amit Roy & Manish Gupta. (2019) Evaluation of covariate effects on pharmacokinetics of monoclonal antibodies in oncology. British Journal of Clinical Pharmacology 85:9, pages 2045-2058.
Crossref
Vic Arendt, Mathieu Amand, Gilles Iserentant, Morgane Lemaire, Cécile Masquelier, Gilles F Ndayisaba, Chris Verhofstede, Etienne Karita, Susan Allen, Andy Chevigné, Jean‐Claude Schmit, Danielle Perez Bercoff & Carole Seguin‐Devaux. (2019) Predominance of the heterozygous CCR 5 delta‐24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR 5 addressing at the cell surface . Journal of the International AIDS Society 22:9.
Crossref
Yumiko Masuda, Masashi Tsuda, Chie Hashikawa‐Muto, Yusuke Takahashi, Koichi Nonaka & Kaori Wakamatsu. (2019) Cation exchange chromatography performed in overloaded mode is effective in removing viruses during the manufacturing of monoclonal antibodies. Biotechnology Progress 35:5.
Crossref
Margherita Passariello, Simona Camorani, Cinzia Vetrei, Laura Cerchia & Claudia De Lorenzo. (2019) Novel Human Bispecific Aptamer–Antibody Conjugates for Efficient Cancer Cell Killing. Cancers 11:9, pages 1268.
Crossref
Nazlı Eda Kaleli, Murat Karadag & Sibel Kalyoncu. (2019) Phage display derived therapeutic antibodies have enriched aliphatic content: Insights for developability issues. Proteins: Structure, Function, and Bioinformatics 87:7, pages 607-618.
Crossref
Nobuo Fukuda, Yukako Senga & Shinya Honda. (2019) Anxa2 ‐ and Ctsd ‐knockout CHO cell lines to diminish the risk of contamination with host cell proteins . Biotechnology Progress 35:4.
Crossref
Kevin O. Saunders. (2019) Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life. Frontiers in Immunology 10.
Crossref
Sebastian Daberdaku & Carlo Ferrari. (2019) Antibody interface prediction with 3D Zernike descriptors and SVM. Bioinformatics 35:11, pages 1870-1876.
Crossref
Sepideh Jalilzadeh-Razin, Malihe Mantegi, Mohammad R. Tohidkia, Yaghub Pazhang, Mohammad M. Pourseif, Jaleh Barar & Yadollah Omidi. (2019) Phage antibody library screening for the selection of novel high-affinity human single-chain variable fragment against gastrin receptor: an in silico and in vitro study. DARU Journal of Pharmaceutical Sciences 27:1, pages 21-34.
Crossref
Alex J. Poot, Kevin W.A. Adamzek, Albert D. Windhorst, Maria J.W.D. Vosjan, Saskia Kropf, Hans-Jurgen Wester, Guus A.M.S. van Dongen & Danielle J. Vugts. (2019) Fully Automated 89 Zr Labeling and Purification of Antibodies . Journal of Nuclear Medicine 60:5, pages 691-695.
Crossref
Yu Tang, Kshitij Parag-Sharma, Antonio L. Amelio & Yanguang Cao. (2019) A Bioluminescence Resonance Energy Transfer-Based Approach for Determining Antibody-Receptor Occupancy In Vivo. iScience 15, pages 439-451.
Crossref
John F. Kellie, Andrew S. Thomson, Shugui Chen, Sarah L. Childs, Molly Z. Karlinsey, Shing H. Mai, John R. White & Robert A. Biddlecombe. (2019) Biotherapeutic Antibody Subunit LC-MS and Peptide Mapping LC-MS Measurements to Study Possible Biotransformation and Critical Quality Attributes In Vivo. Journal of Pharmaceutical Sciences 108:4, pages 1415-1422.
Crossref
Mouldy Sioud. (2019) Phage Display Libraries: From Binders to Targeted Drug Delivery and Human Therapeutics. Molecular Biotechnology 61:4, pages 286-303.
Crossref
Manyu Luo, Meiqi Zhao, Cedric Cagliero, Hua Jiang, Yueqing Xie, Jianwei Zhu, Hui Yang, Mengxiao Zhang, Ying Zheng, Yunsheng Yuan, Zixiu Du & Huili Lu. (2019) A general platform for efficient extracellular expression and purification of Fab from Escherichia coli. Applied Microbiology and Biotechnology 103:8, pages 3341-3353.
Crossref
Aditya Utturkar, Keith Gillette, Chia‐Yun Sun, Mark Pagkaliwangan, Rachel Quesenberry & Mark Schofield. (2018) A Direct Approach for Process Development Using Single Column Experiments Results in Predictable Streamlined Multi‐Column Chromatography Bioprocesses. Biotechnology Journal 14:4.
Crossref
Yu-Wen Lo, Ming-Thau Sheu, Wen-Hsuan Chiang, Ya-Ling Chiu, Chia-Mu Tu, Wen-Yu Wang, Ming-Hsi Wu, Yu-Cheng Wang, Maggie Lu & Hsiu-O Ho. (2019) In situ chemically crosslinked injectable hydrogels for the subcutaneous delivery of trastuzumab to treat breast cancer. Acta Biomaterialia 86, pages 280-290.
Crossref
Tiffany A. Peterson & Andrew G. MacLean. (2018) Current and Future Therapeutic Strategies for Lentiviral Eradication from Macrophage Reservoirs. Journal of Neuroimmune Pharmacology 14:1, pages 68-93.
Crossref
Beatriz G. de la Torre & Fernando Albericio. (2019) The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules 24:4, pages 809.
Crossref
Tomas Di Mambro, Ilaria Guerriero, Luigi Aurisicchio, Mauro Magnani & Emanuele Marra. (2019) The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?. Frontiers in Pharmacology 10.
Crossref
Xiufeng Wu & Stephen J. Demarest. (2019) Building blocks for bispecific and trispecific antibodies. Methods 154, pages 3-9.
Crossref
Dong-Jun Bae, Sang-Yeob Kim, Sang Mun Bae, Ae-Kyung Hwang, Kwan Cheol Pak, SeokKyu Yoon & Hyeong-Seok Lim. (2019) Whole-Body Physiologically Based Pharmacokinetic Modeling of Trastuzumab and Prediction of Human Pharmacokinetics. Journal of Pharmaceutical Sciences.
Crossref
Paula J. Busse, Henriette Farkas, Aleena Banerji, William R. Lumry, Hilary J. Longhurst, Daniel J. Sexton & Marc A. Riedl. (2018) Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies. BioDrugs 33:1, pages 33-43.
Crossref
Qun Zhou. 2019. Immune Aspects of Biopharmaceuticals and Nanomedicines. Immune Aspects of Biopharmaceuticals and Nanomedicines 155 182 .
E. Carlos Rodriguez‐Merchan & Leonard A. Valentino. (2018) Emicizumab: Review of the literature and critical appraisal. Haemophilia 25:1, pages 11-20.
Crossref
Yiran Zhang, Chun Fan, Lijuan Zhang & Xuexiao Ma. 2019. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B 471 485 .
Meng Zhang, Huaiqian Dou, Dandan Yang, Ming Shan, Xiulian Li, Cui Hao, Yiran Zhang, Pengjiao Zeng, Yanli He, Yong Liu, Jing Fu, Wei Wang, Minghui Hu, Hui Li, Qingwu Tian, Shuhe Lei & Lijuan Zhang. 2019. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A 141 163 .
Tyler Hageman, Hui Wei, Patrick Kuehne, Jinmei Fu, Richard Ludwig, Li Tao, Anthony Leone, Marcel Zocher & Tapan K. Das. (2018) Impact of Tryptophan Oxidation in Complementarity-Determining Regions of Two Monoclonal Antibodies on Structure-Function Characterized by Hydrogen-Deuterium Exchange Mass Spectrometry and Surface Plasmon Resonance. Pharmaceutical Research 36:1.
Crossref
Danielle J. Vugts & Guus A. M. S. van Dongen. 2019. Radiopharmaceutical Chemistry. Radiopharmaceutical Chemistry 163 179 .
Jinwoo Leem & Charlotte M. Deane. 2019. Computational Methods in Protein Evolution. Computational Methods in Protein Evolution 367 380 .
Aleksandr Kovaltsuk, Konrad Krawczyk, Sebastian Kelm, James Snowden & Charlotte M. Deane. (2018) Filtering Next-Generation Sequencing of the Ig Gene Repertoire Data Using Antibody Structural Information. The Journal of Immunology 201:12, pages 3694-3704.
Crossref
Yu V Kalyuzhnyi & V Vlachy. (2018) Modeling the depletion effect caused by an addition of polymer to monoclonal antibody solutions. Journal of Physics: Condensed Matter 30:48, pages 485101.
Crossref
Lu Shan, Neil Mody, Pietro SormaniKim L. Rosenthal, Melissa M. Damschroder & Reza Esfandiary. (2018) Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools. Molecular Pharmaceutics 15:12, pages 5697-5710.
Crossref
Miriam Colombo, Maria Antonietta Rizzuto, Chiara Pacini, Laura Pandolfi, Arianna Bonizzi, Marta Truffi, Matteo Monieri, Francesco Catrambone, Marco Giustra, Stefania Garbujo, Luisa Fiandra, Fabio Corsi, Davide Prosperi & Serena Mazzucchelli. (2018) Half-Chain Cetuximab Nanoconjugates Allow Multitarget Therapy of Triple Negative Breast Cancer. Bioconjugate Chemistry 29:11, pages 3817-3832.
Crossref
Meric Ovacik & Kedan Lin. (2018) Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development. Clinical and Translational Science 11:6, pages 540-552.
Crossref
Patrick J. Kennedy, Flavia Sousa, Daniel Ferreira, Carla Pereira, Marika Nestor, Carla Oliveira, Pedro L. Granja & Bruno Sarmento. (2018) Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6. Acta Biomaterialia 81, pages 208-218.
Crossref
Subhabrata Majumder, Michael T. Jones, Michael Kimmel & Arun Alphonse Ignatius. (2018) Probing Conformational Diversity of Fc Domains in Aggregation-Prone Monoclonal Antibodies. Pharmaceutical Research 35:11.
Crossref
Kerry R Love, Neil C Dalvie & J Christopher Love. (2018) The yeast stands alone: the future of protein biologic production. Current Opinion in Biotechnology 53, pages 50-58.
Crossref
Christian Schröter, Jan Beck, Simon Krah, Stefan Zielonka, Achim Doerner, Laura Rhiel, Ralf Günther, Lars Toleikis, Harald Kolmar, Björn Hock & Stefan Becker. (2018) Selection of Antibodies with Tailored Properties by Application of High-Throughput Multiparameter Fluorescence-Activated Cell Sorting of Yeast-Displayed Immune Libraries. Molecular Biotechnology 60:10, pages 727-735.
Crossref
Dheeraj S. Tomar, Satish K. Singh, Li Li, Matthew P. Broulidakis & Sandeep Kumar. (2018) In Silico Prediction of Diffusion Interaction Parameter (kD), a Key Indicator of Antibody Solution Behaviors. Pharmaceutical Research 35:10.
Crossref
Luhong He, Jairav X. Desai, Jinxin Gao, Laurie B. Hazeltine, Zhirui Lian, John N. Calley & Christopher C. Frye. (2018) Elucidating the Impact of CHO Cell Culture Media on Tryptophan Oxidation of a Monoclonal Antibody Through Gene Expression Analyses. Biotechnology Journal 13:10.
Crossref
Martin Dalziel, Stephen A Beers, Mark S Cragg & Max Crispin. (2018) Through the barricades: overcoming the barriers to effective antibody-based cancer therapeutics. Glycobiology 28:9, pages 697-712.
Crossref
Edgar Liberis, Petar Veličković, Pietro Sormanni, Michele Vendruscolo & Pietro Liò. (2018) Parapred: antibody paratope prediction using convolutional and recurrent neural networks. Bioinformatics 34:17, pages 2944-2950.
Crossref
Ilaria Scurci, Elsa Martins & Oliver Hartley. (2018) CCR5: Established paradigms and new frontiers for a ‘celebrity’ chemokine receptor. Cytokine 109, pages 81-93.
Crossref
Chen Qiu & Sergey Arzhantsev. (2018) Secondary structure assessment of formulated bevacizumab in the presence of SDS by deep ultraviolet resonance Raman (DUVRR) spectroscopy. Analytical Biochemistry 555, pages 26-32.
Crossref
Ilokugbe Ettah & Lorna Ashton. (2018) Engaging with Raman Spectroscopy to Investigate Antibody Aggregation. Antibodies 7:3, pages 24.
Crossref
Theo Pirich, Elisabeth Zwickl-Traxler, Martin Pecherstorfer & Josef Singer. (2018) Tolerability of obinutuzumab therapy in patients with rituximab-relapsed/refractory B-cell malignancies - a retrospective single center cohort study. Oncotarget 9:52, pages 29944-29956.
Crossref
Frank A. Engler, Joseph Ryan Polli, Tommy Li, Bo An, Michael Otteneder, Jun Qu & Joseph P. Balthasar. (2018) “Catch-and-Release” Anti-Carcinoembryonic Antigen Monoclonal Antibody Leads to Greater Plasma and Tumor Exposure in a Mouse Model of Colorectal Cancer. Journal of Pharmacology and Experimental Therapeutics 366:1, pages 205-219.
Crossref
Xiufeng Wu, Richard Yuan, Michael Bacica & Stephen J Demarest. (2018) Generation of orthogonal Fab-based trispecific antibody formats. Protein Engineering, Design and Selection 31:7-8, pages 249-256.
Crossref
Hélène Chapy & Leonid Kagan. (2018) Evaluation of the Effects of Animal Growth and Previous Exposure on the Pharmacokinetics of Rituximab in Rats. Journal of Pharmaceutical Sciences 107:7, pages 1987-1994.
Crossref
Ankita Solanki, Lokesh Kumar Bhatt & Thomas P. Johnston. (2018) Evolving targets for the treatment of atherosclerosis. Pharmacology & Therapeutics 187, pages 1-12.
Crossref
Delphine Vivier, Sai Kiran Sharma & Brian M. Zeglis. (2018) Understanding the in vivo fate of radioimmunoconjugates for nuclear imaging. Journal of Labelled Compounds and Radiopharmaceuticals 61:9, pages 672-692.
Crossref
Wen‐Ting K. Tsai & Anna M. Wu. (2018) Aligning physics and physiology: E ngineering antibodies for radionuclide delivery . Journal of Labelled Compounds and Radiopharmaceuticals 61:9, pages 693-714.
Crossref
Lukas M. Carter, Sophie Poty, Sai Kiran Sharma & Jason S. Lewis. (2018) Preclinical optimization of antibody‐based radiopharmaceuticals for cancer imaging and radionuclide therapy—Model, vector, and radionuclide selection. Journal of Labelled Compounds and Radiopharmaceuticals 61:9, pages 611-635.
Crossref
Dana N Ashoor, Noureddine Ben Khalaf, Sonia Bourguiba-Hachemi, Maryam H Marzouq & M Dahmani Fathallah. (2018) Engineering of the upper hinge region of human IgG1 Fc enhances the binding affinity to FcγIIIa (CD16a) receptor isoform. Protein Engineering, Design and Selection 31:6, pages 205-212.
Crossref
Matthew H. Bakalar, Aaron M. Joffe, Eva M. Schmid, Sungmin Son, Marija Podolski & Daniel A. Fletcher. (2018) Size-Dependent Segregation Controls Macrophage Phagocytosis of Antibody-Opsonized Targets. Cell 174:1, pages 131-142.e13.
Crossref
Francis S. Wolenski, Cindy Q. Xia, Bingli Ma, Tae H. Han, Wen C. Shyu & Suresh K. Balani. (2017) CYP Suppression in Human Hepatocytes by Monomethyl Auristatin E, the Payload in Brentuximab Vedotin (Adcetris®), is Associated with Microtubule Disruption. European Journal of Drug Metabolism and Pharmacokinetics 43:3, pages 347-354.
Crossref
Shuayb Elkhalifa, Siddiq Anwar & Yousuf Karim. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences 1 11 .
Beatriz Trastoy, Erik Klontz, Jared Orwenyo, Alberto Marina, Lai-Xi Wang, Eric J. Sundberg & Marcelo E. Guerin. (2018) Structural basis for the recognition of complex-type N-glycans by Endoglycosidase S. Nature Communications 9:1.
Crossref
Gustavo A. Arias-Pinilla, Angus G. Dalgleish, Satvinder Mudan, Izhar Bagwan, Anthony J. Walker & Helmout Modjtahedi. (2018) Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer. Oncotarget 9:28, pages 19994-20007.
Crossref
Sai Kiran Sharma, Andrew Chow, Sebastien Monette, Delphine Vivier, Jacob Pourat, Kimberly J. Edwards, Thomas R. Dilling, Dalya Abdel-Atti, Brian M. Zeglis, John T. Poirier & Jason S. Lewis. (2018) Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models. Cancer Research 78:7, pages 1820-1832.
Crossref
Caroline Soliman, Anna K. Walduck, Elizabeth Yuriev, Jack S. Richards, Colette Cywes-Bentley, Gerald B. Pier & Paul A. Ramsland. (2018) Structural basis for antibody targeting of the broadly expressed microbial polysaccharide poly-N-acetylglucosamine. Journal of Biological Chemistry 293:14, pages 5079-5089.
Crossref
Deepti Ahluwalia, Madesh Belakavadi, Tapan K. Das & Amit Katiyar. (2018) A three-point identity criteria tool for establishing product identity using icIEF method. Journal of Chromatography B 1083, pages 271-277.
Crossref
Christoph Niederalt, Lars Kuepfer, Juri Solodenko, Thomas Eissing, Hans-Ulrich Siegmund, Michael Block, Stefan Willmann & Jörg Lippert. (2017) A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-Sim. Journal of Pharmacokinetics and Pharmacodynamics 45:2, pages 235-257.
Crossref
Jinwoo Leem, Guy Georges, Jiye Shi & Charlotte M. Deane. (2018) Antibody side chain conformations are position-dependent. Proteins: Structure, Function, and Bioinformatics 86:4, pages 383-392.
Crossref
Aitor Nogales, Michael S. Piepenbrink, Jiong Wang, Sandra Ortega, Madhubanti Basu, Christopher F. Fucile, John J. Treanor, Alexander F. Rosenberg, Martin S. Zand, Michael C. Keefer, Luis Martinez-Sobrido & James J. Kobie. (2018) A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody. Scientific Reports 8:1.
Crossref
Paul J. Carter & Greg A. Lazar. (2017) Next generation antibody drugs: pursuit of the 'high-hanging fruit'. Nature Reviews Drug Discovery 17:3, pages 197-223.
Crossref
Petra Verdino, Shane Atwell & Stephen J Demarest. (2018) Emerging trends in bispecific antibody and scaffold protein therapeutics. Current Opinion in Chemical Engineering 19, pages 107-123.
Crossref
Darren E. Ferguson, Evan R. Mahan, Weijun Ma, Gabrielle Bitzas, Xiaotian Zhong, Richard Zollner & Aaron M. D’Antona. (2018) Parallel loading and complete automation of a 3-step mAb purification process for multiple samples using a customized preparative chromatography instrument with networked pumps. Journal of Chromatography A 1542, pages 50-60.
Crossref
Maria Monica Castellanos, Steven C. Howell, D. Travis Gallagher & Joseph E. Curtis. (2018) Characterization of the NISTmAb Reference Material using small-angle scattering and molecular simulation. Analytical and Bioanalytical Chemistry 410:8, pages 2141-2159.
Crossref
Beatriz de la Torre & Fernando Albericio. (2018) The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules 23:3, pages 533.
Crossref
Lilian Rumi Tsuruta, Mariana Lopes dos & Ana Maria Moro. 2018. Antibody Engineering. Antibody Engineering.
María Elena Iezzi, Lucía Policastro, Santiago Werbajh, Osvaldo Podhajcer & Gabriela Alicia Canziani. (2018) Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment. Frontiers in Immunology 9.
Crossref
June Ereño-Orbea, Taylor Sicard, Hong Cui, Jacob Carson, Pim Hermans & Jean-Philippe Julien. (2018) Structural Basis of Enhanced Crystallizability Induced by a Molecular Chaperone for Antibody Antigen-Binding Fragments. Journal of Molecular Biology 430:3, pages 322-336.
Crossref
Nachiket Shembekar, Hongxing Hu, David Eustace & Christoph A. Merten. (2018) Single-Cell Droplet Microfluidic Screening for Antibodies Specifically Binding to Target Cells. Cell Reports 22:8, pages 2206-2215.
Crossref
Luca Vangelista & Sandro Vento. (2018) The Expanding Therapeutic Perspective of CCR5 Blockade. Frontiers in Immunology 8.
Crossref
Chunpeng Yang, Xinyu Gao & Rui Gong. (2018) Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics. Frontiers in Immunology 8.
Crossref
Juan C. Almagro, Tracy R. Daniels-Wells, Sonia Mayra Perez-Tapia & Manuel L. Penichet. (2018) Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. Frontiers in Immunology 8.
Crossref
Yuwei Tian & Brandon T. Ruotolo. (2018) The growing role of structural mass spectrometry in the discovery and development of therapeutic antibodies. The Analyst 143:11, pages 2459-2468.
Crossref
Christopher D. Spicer, Coline Jumeaux, Bakul Gupta & Molly M. Stevens. (2018) Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications. Chemical Society Reviews 47:10, pages 3574-3620.
Crossref
Babita Saxena Parekh, Arvind Srivastava, Shanmuuga Sundaram, Ming Ching-Heish, Joel Goldstein, Michael Barry & Qinwei Zhou. (2018) Correlating charge heterogeneity data generated by agarose gel isoelectric focusing and ion exchange chromatography methods. Journal of Chromatography B 1073, pages 1-9.
Crossref
Steffen Großhans, Gang Wang, Christian Fischer & Jürgen Hubbuch. (2018) An integrated precipitation and ion-exchange chromatography process for antibody manufacturing: Process development strategy and continuous chromatography exploration. Journal of Chromatography A 1533, pages 66-76.
Crossref
Günter Jagschies. 2018. Biopharmaceutical Processing. Biopharmaceutical Processing 59 72 .
Xinhua Wang, Mary Mathieu & Randall J. Brezski. (2017) IgG Fc engineering to modulate antibody effector functions. Protein & Cell 9:1, pages 63-73.
Crossref
Rudo Simeon & Zhilei Chen. (2017) In vitro-engineered non-antibody protein therapeutics. Protein & Cell 9:1, pages 3-14.
Crossref
Fernando Velayos. 2018. Treatment of Inflammatory Bowel Disease with Biologics. Treatment of Inflammatory Bowel Disease with Biologics 303 313 .
Déborah Caucheteur, Gautier Robin, Vincent Parez & Pierre Martineau. 2018. Antibody Engineering. Antibody Engineering 93 108 .
Déborah Caucheteur, Gautier Robin, Vincent Parez & Pierre Martineau. 2018. Phage Display. Phage Display 239 253 .
Roxana-Maria Rujan & Christopher A. Reynolds. 2019. Calcitonin Gene-Related Peptide (CGRP) Mechanisms. Calcitonin Gene-Related Peptide (CGRP) Mechanisms 169 192 .
Michael W. Handlogten, Allison Lee‐O'Brien, Gargi Roy, Sophia V. Levitskaya, Raghavan Venkat, Shailendra Singh & Sanjeev Ahuja. (2017) Intracellular response to process optimization and impact on productivity and product aggregates for a high‐titer CHO cell process. Biotechnology and Bioengineering 115:1, pages 126-138.
Crossref
Qiong Dai, Nadja Bertleff‐Zieschang, Julia A. Braunger, Mattias Björnmalm, Christina Cortez‐Jugo & Frank Caruso. (2017) Particle Targeting in Complex Biological Media. Advanced Healthcare Materials 7:1, pages 1700575.
Crossref
Isabel Corraliza-Gorjón, Beatriz Somovilla-Crespo, Silvia Santamaria, Jose A. Garcia-Sanz & Leonor Kremer. (2017) New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness. Frontiers in Immunology 8.
Crossref
Yanling Wu, Shibo Jiang & Tianlei Ying. (2017) Single-Domain Antibodies As Therapeutics against Human Viral Diseases. Frontiers in Immunology 8.
Crossref
Aleksandr Kovaltsuk, Konrad Krawczyk, Jacob D. Galson, Dominic F. Kelly, Charlotte M. Deane & Johannes Trück. (2017) How B-Cell Receptor Repertoire Sequencing Can Be Enriched with Structural Antibody Data. Frontiers in Immunology 8.
Crossref
Kevin Hollevoet & Paul J. Declerck. (2017) State of play and clinical prospects of antibody gene transfer. Journal of Translational Medicine 15:1.
Crossref
Tushar Jain, Todd Boland, Asparouh Lilov, Irina Burnina, Michael Brown, Yingda Xu & Maximiliano Vásquez. (2017) Prediction of delayed retention of antibodies in hydrophobic interaction chromatography from sequence using machine learning. Bioinformatics 33:23, pages 3758-3766.
Crossref
Emma Hays, Wei Duan & Sarah Shigdar. (2017) Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications. International Journal of Molecular Sciences 18:12, pages 2576.
Crossref
Wei Li, Zhongyu Zhu, Weizao Chen, Yang Feng & Dimiter S. Dimitrov. (2017) Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development. Frontiers in Immunology 8.
Crossref
Qun Zhou. (2017) Site-Specific Antibody Conjugation for ADC and Beyond. Biomedicines 5:4, pages 64.
Crossref
Mohammad A. Obeid, Mohammed M. Al Qaraghuli, Manal Alsaadi, Abdullah R. Alzahrani, Kanidta Niwasabutra & Valerie A. Ferro. (2017) Delivering natural products and biotherapeutics to improve drug efficacy. Therapeutic Delivery 8:11, pages 947-956.
Crossref
Catherine J. Hutchings, Markus Koglin, William C. Olson & Fiona H. Marshall. (2017) Opportunities for therapeutic antibodies directed at G-protein-coupled receptors. Nature Reviews Drug Discovery 16:11, pages 787-810.
Crossref
C. Lamesa, M.-D. Desruet, R. Mazet, J.-P. Vuillez & A.-S. Gauchez. (2017) Un test rapide d’évaluation des anticorps humains anti-souris (HAMA). Médecine Nucléaire 41:6, pages 415-417.
Crossref
Michal Nemergut, Gabriel Žoldák, Jonas V. Schaefer, Florian Kast, Pavol Miškovský, Andreas Plückthun & Erik Sedlák. (2017) Analysis of IgG kinetic stability by differential scanning calorimetry, probe fluorescence and light scattering. Protein Science 26:11, pages 2229-2239.
Crossref
John Steven, Mischa R. Müller, Miguel F. Carvalho, Obinna C. Ubah, Marina Kovaleva, Gerard Donohoe, Thomas Baddeley, Dawn Cornock, Kenneth Saunders, Andrew J. Porter & Caroline Jane Barelle. (2017) In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties to Facilitate Clinical Development. Frontiers in Immunology 8.
Crossref
Michael J. E. Marshall, Richard J. Stopforth & Mark S. Cragg. (2017) Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?. Frontiers in Immunology 8.
Crossref
Qing Wang, Jiangbin Han, Chunjie Sha, Yuanyingzhu Liang, Yiying Sun, Xin Shao, Jiye Sun & Wanhui Liu. (2017) Novel strategy using tryptic peptide immunoaffinity-based LC–MS/MS to quantify denosumab in monkey serum. Bioanalysis 9:19, pages 1451-1463.
Crossref
Alexandre Goyon, Melissa Excoffier, Marie-Claire Janin-Bussat, Balazs Bobaly, Szabolcs Fekete, Davy Guillarme & Alain Beck. (2017) Determination of isoelectric points and relative charge variants of 23 therapeutic monoclonal antibodies. Journal of Chromatography B 1065-1066, pages 119-128.
Crossref
Nikolaos G. Papadopoulos, Spyridon Megremis, Nikolaos A. Kitsioulis, Olympia Vangelatou, Peter West & Paraskevi Xepapadaki. (2017) Promising approaches for the treatment and prevention of viral respiratory illnesses. Journal of Allergy and Clinical Immunology 140:4, pages 921-932.
Crossref
Michael D. Jain & John Kuruvilla. (2017) Anti-PD-1 Antibodies as a Therapeutic Strategy in Classical Hodgkin Lymphoma. Drugs 77:15, pages 1645-1655.
Crossref
Saeko Yanaka, Toshio Yamazaki, Rina Yogo, Masanori Noda, Susumu Uchiyama, Hirokazu Yagi & Koichi Kato. (2017) NMR Detection of Semi-Specific Antibody Interactions in Serum Environments. Molecules 22:10, pages 1619.
Crossref
M. Stech, O. Nikolaeva, L. Thoring, W. F. M. Stöcklein, D. A. Wüstenhagen, M. Hust, S. Dübel & S. Kubick. (2017) Cell-free synthesis of functional antibodies using a coupled in vitro transcription-translation system based on CHO cell lysates. Scientific Reports 7:1.
Crossref
Masahiro Yasunaga, Shino Manabe & Yasuhiro Matsumura. (2017) Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease. Scientific Reports 7:1.
Crossref
Melissa M. Remy, Mehmet Sahin, Lukas Flatz, Tommy Regen, Lifen Xu, Mario Kreutzfeldt, Benedict Fallet, Camille Doras, Toni Rieger, Lukas Bestmann, Uwe-Karsten Hanisch, Beat A. Kaufmann, Doron Merkler & Daniel D. Pinschewer. (2017) Interferon-γ-Driven iNOS: A Molecular Pathway to Terminal Shock in Arenavirus Hemorrhagic Fever. Cell Host & Microbe 22:3, pages 354-365.e5.
Crossref
Doreen Könning, Laura Rhiel, Martin Empting, Julius Grzeschik, Carolin Sellmann, Christian Schröter, Stefan Zielonka, Stephan Dickgießer, Thomas Pirzer, Desislava Yanakieva, Stefan Becker & Harald Kolmar. (2017) Semi-synthetic vNAR libraries screened against therapeutic antibodies primarily deliver anti-idiotypic binders. Scientific Reports 7:1.
Crossref
Xiaoqiu Wu, Atik Shaikh, Yuanyuan Yu, Yongshu Li, Shuaijian Ni, Aiping Lu & Ge Zhang. (2017) Potential Diagnostic and Therapeutic Applications of Oligonucleotide Aptamers in Breast Cancer. International Journal of Molecular Sciences 18:9, pages 1851.
Crossref
Pietro Sormanni, Leanne Amery, Sofia Ekizoglou, Michele Vendruscolo & Bojana Popovic. (2017) Rapid and accurate in silico solubility screening of a monoclonal antibody library. Scientific Reports 7:1.
Crossref

Displaying 200 of 208 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.